Low c-peptide is associated with high glycaemic variability and hypoglycaemia in insulin-treated patients with Type 2 diabetes

被引：0
|
作者：
Hope, S. V. [1 ,2 ]
Knight, B. A. [1 ,2 ]
Shields, B. M. [1 ,2 ]
Strain, W. D. [1 ,2 ]
Hattersley, A. T. [1 ,2 ]
Choudhary, P. [3 ]
Jones, A. G. [1 ,2 ]
机构：
[1] Univ Exeter, Exeter Natl Inst Hlth Res Clin Res Facil, Exeter, Devon, England
[2] Royal Devon & Exeter NHS Fdn Trust, Exeter, Devon, England
[3] Kings Coll London, Diabet Res Grp, London WC2R 2LS, England
来源：
DIABETIC MEDICINE | 2016年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A39
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [31] ASSOCIATED FACTORS OF EJECTION FRACTION IN INSULIN-TREATED PATIENTS WITH TYPE 2 DIABETES
    Botnariu, Gina
    Petris, A. O.
    Petris, O. R.
    Popa, Alina D.
    Costache, Irina Iuliana
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2014, 118 (04): : 946 - 952
  • [32] Predictors of hypoglycaemia in insulin-treated type 2 diabetes patients in primary care: A retrospective database analysis
    Kostev, Karel
    Dippel, Franz-Werner
    Rathmann, Wolfgang
    PRIMARY CARE DIABETES, 2014, 8 (02) : 127 - 131
  • [33] Perioperative glycaemic control in insulin-treated type 2 diabetes patients undergoing gastric bypass surgery
    Cruijsen, M.
    Koehestani, P.
    Huttjes, S.
    Leenders, K.
    Janssen, I.
    de Boer, H.
    NETHERLANDS JOURNAL OF MEDICINE, 2014, 72 (04): : 202 - 209
  • [34] POORER ENDOGENOUS C-PEPTIDE RESPONSE IN INSULIN TREATED ADOLESCENTS WITH TYPE 2 DIABETES
    Barr, M. M.
    Ashraf, A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (02) : 400 - 400
  • [35] Urine C-peptide creatinine ratio is an alternative to stimulated serum C-peptide measurement in late-onset, insulin-treated diabetes
    Jones, A. G.
    Besser, R. E. J.
    McDonald, T. J.
    Shields, B. M.
    Hope, S. V.
    Bowman, P.
    Oram, R. A.
    Knight, B. A.
    Hattersley, A. T.
    DIABETIC MEDICINE, 2011, 28 (09) : 1034 - 1038
  • [36] Association of fasting C-peptide levels with glycaemic efficacy and risk of hypoglycaemia in people with type 2 diabetes commencing insulin glargine 100 U/ml
    Owens, D. R.
    Landgraf, W.
    Zhang, M.
    Traylor, L.
    Frier, B. M.
    Bolli, G. B.
    Home, P. D.
    DIABETOLOGIA, 2017, 60 : S35 - S36
  • [37] Long-term Effects of Metformin on Plasma Concentrations of C-Peptide in Insulin-Treated Type 2 Diabetes Patients: A Placebo-Controlled Trial
    Top, Wiebe M. C.
    Kooy, Adriaan
    Lehert, Philippe
    Stehouwer, Coen D.
    DIABETES, 2014, 63 : A551 - A551
  • [38] The potential of predicting nocturnal hypoglycaemia for insulin-treated individuals with type 2 diabetes in telemonitoring
    Kronborg, T.
    Hangaard, S.
    Hejlesen, O.
    Vestergaard, P.
    Jensen, M. H.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S379 - S380
  • [39] Hypoglycaemia in insulin-treated Type 2 diabetes mellitus: frequency, symptoms and impaired awareness
    Allen, KV
    Henderson, JN
    Deary, IJ
    Frier, BM
    DIABETOLOGIA, 2002, 45 : A268 - A268
  • [40] Fear of hypoglycaemia was not associated with glycaemic variability in patients with type 1 diabetes: the VARDIA study
    Hadjadj, S.
    Gand, E.
    Chaillous, L.
    Dubois, S.
    Bonnet, F.
    Fradet, G.
    Crespin, I. Delcourt
    Kerlan, V.
    Gouet, D.
    Perlemoine, C.
    Ducluzeau, P-H.
    Pichelin, M.
    Ragot, S.
    Saulnier, P-J.
    Cariou, B.
    DIABETOLOGIA, 2017, 60 : S336 - S337
12345